ResMed Inc.

BOVESPA:R1MD34 Stock Report

Market Cap: R$217.7b

ResMed Future Growth

Future criteria checks 2/6

ResMed is forecast to grow earnings and revenue by 11.1% and 7.1% per annum respectively. EPS is expected to grow by 11.1% per annum. Return on equity is forecast to be 22% in 3 years.

Key information

11.1%

Earnings growth rate

11.1%

EPS growth rate

Medical Equipment earnings growth18.3%
Revenue growth rate7.1%
Future return on equity22.0%
Analyst coverage

Good

Last updated04 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:R1MD34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20275,8901,6091,6021,72418
6/30/20265,4941,4711,5011,59521
6/30/20255,1241,3281,2671,38822
9/30/20244,8071,1131,3471,441N/A
6/30/20244,6851,0211,2861,401N/A
3/31/20244,5849581,0711,199N/A
12/31/20234,5048909441,079N/A
9/30/20234,375907792935N/A
6/30/20234,223898559693N/A
3/31/20234,016863408535N/A
12/31/20223,763809222370N/A
9/30/20223,624786305461N/A
6/30/20223,578779195351N/A
3/31/20223,539779344498N/A
12/31/20213,444522446577N/A
9/30/20213,349500397527N/A
6/30/20213,197475620737N/A
3/31/20213,091457733840N/A
12/31/20203,092699774884N/A
9/30/20203,028680684784N/A
6/30/20202,957622696802N/A
3/31/20202,892513505614N/A
12/31/20192,784455420514N/A
9/30/20192,699419487573N/A
6/30/20192,607405382459N/A
3/31/20192,525446374447N/A
12/31/20182,455450385456N/A
9/30/20182,405335390459N/A
6/30/20182,340316N/A505N/A
3/31/20182,273307N/A516N/A
12/31/20172,196285N/A434N/A
9/30/20172,125352N/A422N/A
6/30/20172,067342N/A414N/A
3/31/20172,029324N/A417N/A
12/31/20161,968327N/A474N/A
9/30/20161,893346N/A510N/A
6/30/20161,839352N/A548N/A
3/31/20161,773357N/A505N/A
12/31/20151,742357N/A471N/A
9/30/20151,710353N/A421N/A
6/30/20151,679353N/A383N/A
3/31/20151,641353N/A399N/A
12/31/20141,616352N/A409N/A
9/30/20141,578348N/A387N/A
6/30/20141,555345N/A391N/A
3/31/20141,554331N/A400N/A
12/31/20131,540325N/A406N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: R1MD34's forecast earnings growth (11.1% per year) is above the savings rate (10.4%).

Earnings vs Market: R1MD34's earnings (11.1% per year) are forecast to grow slower than the BR market (12.5% per year).

High Growth Earnings: R1MD34's earnings are forecast to grow, but not significantly.

Revenue vs Market: R1MD34's revenue (7.1% per year) is forecast to grow slower than the BR market (7.4% per year).

High Growth Revenue: R1MD34's revenue (7.1% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: R1MD34's Return on Equity is forecast to be high in 3 years time (22%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y